SELLAS Life Sciences Group, Inc. SLS Proceeds From Interest Received
Proceeds From Interest Received at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromInterestReceived.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s proceeds from interest received.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s proceeds from interest received?
- SELLAS Life Sciences Group, Inc. (SLS) reported proceeds from interest received of $845K in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s proceeds from interest received changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s proceeds from interest received increased by 238.0% year-over-year, from $250K to $845K.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s proceeds from interest received?
- Over 4 years (2021 to 2025), SELLAS Life Sciences Group, Inc.'s proceeds from interest received has grown at a 291.6% compound annual growth rate (CAGR), from $6K to $1.41M.
- What does proceeds from interest received mean?
- This metric represents the cash interest income earned on the company's cash balances, cash equivalents, and short-term investments. It reflects the yield generated from the company's treasury management activities. While typically a minor component for clinical-stage firms, it provides insight into the efficiency of cash management.